Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study
Authors
Keywords
-
Journal
DRUG SAFETY
Volume 44, Issue 12, Pages 1355-1364
Publisher
Springer Science and Business Media LLC
Online
2021-10-23
DOI
10.1007/s40264-021-01119-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial in Japanese and Korean patients
- (2021) Fumihiko Sakai et al. HEADACHE
- Efficacy and safety of fremanezumab for chronic migraine prevention: Multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial in Japanese and Korean patients
- (2021) Fumihiko Sakai et al. HEADACHE
- LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF FREMANEZUMAB IN MIGRAINE: A RANDOMIZED STUDY
- (2020) Peter J. Goadsby et al. NEUROLOGY
- CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications
- (2019) David W Dodick CEPHALALGIA
- Long-term treatment patterns of prophylactic and acute migraine medications and incidence of opioid-related adverse events in patients with migraine
- (2019) Machaon Bonafede et al. CEPHALALGIA
- Real-world treatment patterns and patient-reported outcomes in episodic and chronic migraine in Japan: analysis of data from the Adelphi migraine disease specific programme
- (2019) Kaname Ueda et al. JOURNAL OF HEADACHE AND PAIN
- Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine
- (2018) David W. Dodick et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CGRP as the target of new migraine therapies — successful translation from bench to clinic
- (2018) Lars Edvinsson et al. Nature Reviews Neurology
- Migraine Prophylaxis and Acute Treatment Patterns Among Commercially Insured Patients in the United States
- (2017) J. Michael Woolley et al. HEADACHE
- Fremanezumab for the Preventive Treatment of Chronic Migraine
- (2017) Stephen D. Silberstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis
- (2016) Zsolt Hepp et al. CEPHALALGIA
- Systematic Review of Migraine Prophylaxis Adherence and Persistence
- (2016) Zsolt Hepp et al. JOURNAL OF MANAGED CARE PHARMACY
- Adherence to oral migraine-preventive medications among patients with chronic migraine
- (2014) Zsolt Hepp et al. CEPHALALGIA
- Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study (IBMS-II)
- (2013) Andrew M. Blumenfeld et al. HEADACHE
- Tolerance and Loss of Beneficial Effect During Migraine Prophylaxis: Clinical Considerations
- (2011) Elizabeth W. Loder et al. HEADACHE
- Feasibility and validation of a computer-automated Columbia-Suicide severity rating scale using interactive voice response technology
- (2010) James C. Mundt et al. JOURNAL OF PSYCHIATRIC RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started